サポート ブログ Cell Signaling Pathways

Cell Signaling Pathways

Biointron 2024-01-23 Read time: 4 mins
cell-signalling.jpg
CTLA-4 signaling cascade. Image credit: DOI: 10.21873/anticanres.14870

Cell signaling pathways are essential in enabling the communication between cells and to respond to their environment. These pathways involve a series of molecular events that transmit information from the cell's membrane to the nucleus, ultimately regulating various cellular processes and immune responses.1 Antibodies are often developed against a target of interest, which can be specific proteins or biomarkers of a cell signaling pathway. Examples of pathway categories include immune checkpoint signaling, cytokine signaling, and developmental signaling. 

Immune checkpoint signaling pathways play a crucial role in regulating the immune system's responses to various threats, such as pathogens and abnormal cells. Immune checkpoints are the group of molecules and their receptors that act as gatekeepers of immune responses.2 An example of this is CTLA-4 (Cytotoxic T-Lymphocyte-Associated Protein 4), which acts as an inhibitory receptor to help downregulate immune responses. The CTLA-4 signaling pathway involves the inhibition of T cell receptor (TCR) signaling and downstream signaling pathways. It does this when binding to its ligands, B7-1 (CD80) and B7-2 (CD86), on antigen-presenting cells. By downregulating T cell activity, CTLA-4 contributes to immune tolerance and the prevention of autoimmunity.3

CTLA-4 signaling has been the focus of therapeutic development in the field of cancer immunotherapy. Blockade of CTLA-4 with specific antibodies, such as ipilimumab, has been used to enhance anti-tumor immune responses and was approved by the FDA to treat late-stage melanoma.4 By releasing the inhibition imposed by CTLA-4, the immune system can carry out a stronger response against cancer cells. 

Cytokine signaling pathways involve a diverse group of small proteins called cytokines, which play important roles in cell signaling. They function in a wide range of physiological and pathological processes, including immune responses, inflammation, and tissue repair. Interleukin 6 (IL-6) is a cytokine that regulates the acute phase response and is produced at the site of inflammation. Key components of the IL-6 signaling pathway include the IL-6 receptor (IL-6R), the gp130 co-receptor, and the activation of JAK/STAT (Janus Kinase/Signal Transducer and Activator of Transcription) signaling.5

IL-6 signaling is an important target for therapeutic interventions, including the development of antibodies in the treatment of dysregulated IL-6 signaling, such as rheumatoid arthritis and cytokine release syndrome. Tocilizumab was developed as a humanized antibody to IL-6R and approved to treat moderate to severe rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and systemic juvenile idiopathic arthritis.6

Biointron can help you with your antibody discovery needs, as well as having a catalog of products for in vivo research at Abinivivo. We are dedicated to accelerating your antibody discovery, optimization, and production needs. Our team of experts can provide customized solutions that meet your specific research needs. Contact us to learn more about our services and how we can help accelerate your research and drug development projects.


References:

  1. Nair, A., Chauhan, P., Saha, B., & Kubatzky, K. F. (2019). Conceptual Evolution of Cell Signaling. International Journal of Molecular Sciences, 20(13). https://doi.org/10.3390/ijms20133292

  2. He, X., & Xu, C. (2020). Immune checkpoint signaling and cancer immunotherapy. Cell Research, 30(8), 660-669. https://doi.org/10.1038/s41422-020-0343-4

  3. Sobhani, N., Tardiel-Cyril, D. R., Davtyan, A., Generali, D., Roudi, R., & Li, Y. (2021). CTLA-4 in Regulatory T Cells for Cancer Immunotherapy. Cancers, 13(6). https://doi.org/10.3390/cancers13061440

  4. Mansh, M. (2011). Ipilimumab and Cancer Immunotherapy: A New Hope for Advanced Stage Melanoma. The Yale Journal of Biology and Medicine, 84(4), 381-389. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238313/

  5. Gabay, C. Interleukin-6 and chronic inflammation. Arthritis Res Ther 8 (Suppl 2), S3 (2006). https://doi.org/10.1186/ar1917

  6. Choy, E. H., De Benedetti, F., Takeuchi, T., Hashizume, M., John, M. R., & Kishimoto, T. (2020). Translating IL-6 biology into effective treatments. Nature Reviews Rheumatology, 16(6), 335-345. https://doi.org/10.1038/s41584-020-0419-z


Subscribe to our ブログ

Recent ブログ

The therapeutic efficacy of antibodies is closely related to their ability to recognize and bind specific epitopes on target antigens. Epitopes, or antigenic determinants, are a group of amino acids or other chemical groups that are part of a molecule to which an antibody attaches itself. Epitope characterization can help reveal the mechanism of antibody binding and apply intellectual property (patent) protection for novel antibodies, in addition to designing antibodies with high specificity and minimal cross-reactivity.

Jul 12, 2024
ブログ

Understanding the differences between antibody specificity and selectivity is essential for designing and interpreting antibody-based assays in research for experimental accuracy and data interpretation. Antibody specificity refers to an antibody's ability to recognize and bind to a particular epitope—a unique part of an antigen that elicits an immune response.

Jul 10, 2024
ブログ

Antibody-based assays are essential tools in biomedical research, providing the means to detect, quantify, and visualize specific proteins or antigens within complex biological samples. These assays' efficacy hinges on the antibodies' precise properties. While affinity, avidity, specificity, and selectivity are fundamental to antibody performance, the ultimate impact of these properties is heavily influenced by the experimental context in which the antibody is employed.

Jul 08, 2024
ブログ

Biologics, particularly antibodies, have become indispensable in biomedical research and therapeutic development. Research-use-only (RUO) biologics play a pivotal role in preclinical studies, providing researchers with the necessary tools to explore antibody functions and therapeutic potential in vivo.

Jul 04, 2024
ブログ

お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。